Abstract
Radiotherapy and surgery either alone or in combination are the main modalities of treatment at present. In advanced T3 and T4 lesions survival after surgery or radiotherapy is not more than 20%. By synchronous chemotherapy and radiotherapy in the management of advanced malignancies of head and neck, it is hoped to improve the survival rate. Also surgery in head and neck region should be minimal so that normal physiological functions are maintained.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
